BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 111230
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.111230
Table 3 Comparison of the efficacy outcomes in the automated insulin delivery vs the control arms at the end of the studies
Outcome variables (continuous)
Type of the randomized trial
Number of study reports
Number of participants with outcome analyzed
Pooled effect size, mean differences (95%CI)
P value
I2 (%)
Automated insulin delivery arm
Control arm
TAR > 10 mmol/L (%)All5294186-19.48 (-27.14 to -11.82)< 0.0000173
Crossover36968-20.69 (-33.35 to -8.03)0.00179
Parallel-group2225118-18.38 (-31.42 to -5.35)0.00673
TAR > 13.9 mmol/L (%)All4268160-8.33 (-12.89 to -3.77)0.000371
Crossover24342-8.05 (-17.70 to 1.61)0.1079
Parallel-group2225118-11.71 (-23.51 to 0.08)0.0573
TAR > 20 mmol/L (%)Crossover25251-4.39 (-6.79 to -1.98)0.00040
TBR < 3.9 mmol/L (%)All5294186-0.07 (-0.21 to 0.08)0.3722
Crossover36968-0.17 (-0.42 to 0.09)0.2032
Parallel-group22251180.00 (-0.09 to 0.09)0.990
TBR < 3 mmol/L (%)All5294186-0.01 (-0.03 to 0.02)0.5739
Crossover36968-0.03 (-0.09 to 0.03)0.3269
Parallel-group22251180.00 (-0.02 to 0.02)1.000
Mean SG (mmol/L)All5451335-1.21 (-1.93 to -0.49)0.00183
Crossover36968-1.82 (-3.34 to -0.30)0.0284
Parallel-group2382267-0.66 (-1.34 to 0.03)0.0681
SD of SG (mmol/L)Crossover36968-0.40 (-0.64 to -0.15)0.0010
Coefficient of variation of glucose (%)All52941860.91 (-1.04 to 2.87)0.3668
Crossover369680.51 (-2.90 to 3.93)0.7777
Parallel-group22251181.35 (-0.27 to 2.97)0.1017
Time using continuous glucose monitoring sensor (%)Crossover369682.80 (1.55-4.05)< 0.000113
TDDI (U)All6458344-5.45 (-22.20 to 11.29)0.5274
Crossover3696813.24 (-11.64 to 38.12)0.3065
Parallel-group3389276-21.07 (-30.15 to -11.99)< 0.000010
TDDI (U/kg)All3262150-0.04 (-0.20 to 0.11)0.5953
Crossover252510.06 (-0.20 to 0.32)0.6750
Parallel-group121099-0.13 (-0.24 to -0.02)0.02Not reported


Write to the Help Desk